Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Oct;35(10):2698–2702. doi: 10.1128/jcm.35.10.2698-2702.1997

Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C.

X Forns 1, D Tan 1, H J Alter 1, R H Purcell 1, J Bukh 1
PMCID: PMC230044  PMID: 9316941

Abstract

Serum samples from 96 Spanish hemodialysis patients, as well as serial dilutions of RNA extracted from a reference strain of hepatitis G virus (HGV), were tested for HGV or GB virus C (GBV-C) RNA. Two different reverse transcription (RT)-PCR-based methods of detection were compared for the ability to detect RNA extracted from the samples: an RT-nested PCR assay with primers derived from the 5' noncoding region (5'NC) or nonstructural region 3 (NS3) sequences and a commercially available RT-PCR assay with primers derived from the 5'NC or NS5A sequences. When RT-nested PCR was performed on 10-fold serial dilutions of RNA from the HGV reference strain, the last positive dilution was 10(-7) to 10(-8). With the commercial RT-PCR assay, the last positive dilution was 10(-6) to 10(-7). When equal amounts of RNA extracted from serum samples from 96 hemodialysis patients were tested for HGV or GBV-C RNA, 25 patients (26%) were positive by the RT-nested PCR. However, only 21 (84%) of these 25 positive patients were positive for HGV or GBV-C by the commercial RT-PCR assay. Analysis of the 5'NC and NS3 sequences amplified by RT-nested PCR demonstrated that all but two positive patients had unique HGV or GBV-C sequences. In summary, RT-nested PCR and a commercially available RT-PCR assay for HGV or GBV-C gave concordant results for 96% of the patients tested.

Full Text

The Full Text of this article is available as a PDF (155.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bukh J., Miller R. H., Purcell R. H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995 Feb;15(1):41–63. doi: 10.1055/s-2007-1007262. [DOI] [PubMed] [Google Scholar]
  2. Bukh J., Purcell R. H., Miller R. H. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):187–191. doi: 10.1073/pnas.89.1.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dawson G. J., Schlauder G. G., Pilot-Matias T. J., Thiele D., Leary T. P., Murphy P., Rosenblatt J. E., Simons J. N., Martinson F. E., Gutierrez R. A. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol. 1996 Sep;50(1):97–103. doi: 10.1002/(SICI)1096-9071(199609)50:1<97::AID-JMV16>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  4. Forns X., Fernández-Llama P., Costa J., López-Labrador F. X., Ampurdanés S., Olmedo E., Saiz J. C., Guilera M., López-Pedret J., Sánchez-Tapias J. M. Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant. 1997 May;12(5):956–960. doi: 10.1093/ndt/12.5.956. [DOI] [PubMed] [Google Scholar]
  5. Forns X., Fernández-Llama P., Pons M., Costa J., Ampurdanés S., López-Labrador F. X., Olmedo E., López-Pedret J., Darnell A., Revert L. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant. 1997 Apr;12(4):736–740. doi: 10.1093/ndt/12.4.736. [DOI] [PubMed] [Google Scholar]
  6. Fukushi S., Kurihara C., Ishiyama N., Okamura H., Hoshino F. B., Oya A., Katayama K. Nucleotide sequence of the 5' noncoding region of hepatitis G virus isolated from Japanese patients: comparison with reported isolates. Biochem Biophys Res Commun. 1996 Sep 13;226(2):314–318. doi: 10.1006/bbrc.1996.1353. [DOI] [PubMed] [Google Scholar]
  7. Kao J. H., Chen P. J., Hsiang S. C., Chen W., Chen D. S. Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan. J Infect Dis. 1996 Aug;174(2):410–413. doi: 10.1093/infdis/174.2.410. [DOI] [PubMed] [Google Scholar]
  8. Leary T. P., Muerhoff A. S., Simons J. N., Pilot-Matias T. J., Erker J. C., Chalmers M. L., Schlauder G. G., Dawson G. J., Desai S. M., Mushahwar I. K. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 1996 Jan;48(1):60–67. doi: 10.1002/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  9. Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
  10. Muerhoff A. S., Simons J. N., Leary T. P., Erker J. C., Chalmers M. L., Pilot-Matias T. J., Dawson G. J., Desai S. M., Mushahwar I. K. Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol. 1996 Sep;25(3):379–384. doi: 10.1016/s0168-8278(96)80125-5. [DOI] [PubMed] [Google Scholar]
  11. Pilot-Matias T. J., Carrick R. J., Coleman P. F., Leary T. P., Surowy T. K., Simons J. N., Muerhoff A. S., Buijk S. L., Chalmers M. L., Dawson G. J. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology. 1996 Nov 15;225(2):282–292. doi: 10.1006/viro.1996.0602. [DOI] [PubMed] [Google Scholar]
  12. Sampietro M., Badalamenti S., Graziani G., Como G., Buccianti G., Corbetta N., Ticozzi A., Archenti A., Lunghi G., Penso D. Hepatitis G virus infection in hemodialysis patients. Kidney Int. 1997 Jan;51(1):348–352. doi: 10.1038/ki.1997.43. [DOI] [PubMed] [Google Scholar]
  13. Schlueter V., Schmolke S., Stark K., Hess G., Ofenloch-Haehnle B., Engel A. M. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol. 1996 Nov;34(11):2660–2664. doi: 10.1128/jcm.34.11.2660-2664.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995 Jun;1(6):564–569. doi: 10.1038/nm0695-564. [DOI] [PubMed] [Google Scholar]
  15. Tacke M., Kiyosawa K., Stark K., Schlueter V., Ofenloch-Haehnle B., Hess G., Engel A. M. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 1997 Feb 1;349(9048):318–320. doi: 10.1016/S0140-6736(96)06461-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES